Global Active Pharmaceutical Ingredients Market, 2022 – Market to Reach $175 Billion – Research and Markets

DUBLIN, July 27, 2016 /PRNewswire/ —

Research and Markets has announced the addition of the “Active Pharmaceutical Ingredients Global Market – Forecast to 2022” report to their offering.

Major players in the API market include Teva Active Pharmaceutical Industries Limited (Israel), Ranbaxy Laboratories (India), Dr. Reddy’s Lab (India), Boehringer Ingelheim GmbH (Germany), Lonza group (Switzerland), Lupin (India), Novartis (Switzerland), Aurobindo pharma (India), and Albemarle Corporation (U.S.).

Very few numbers of finished pharmaceutical product manufacturers has their own API manufacturing unit and nobody can make all required APIs in-house. It is basically not easy for API manufacturers in developing countries to ensure a product with quality at a reasonable price. API manufacturing involves conversion of raw materials into API and mixing API and excipients for final formulations. These formulations in the form of tablets, capsules or solutions are packaged and then marketed.

The global API market is segmented based on synthesis, customer base, business type and therapeutic applications. Depending on synthesis the market is classified into synthetic chemical API, biotech API and HPAPI (Highly Potent Active Pharmaceutical Ingredient). Biotech API is further segmented into mammalian cell culture, monoclonal antibodies, recombinant proteins, vaccines, insulin analog, growth hormones and interferons.

Mammalian cell culture accounted for the largest share in 2013, while monoclonal antibody segment is the fastest growing segment by 2020. Despite low production yields, high manufacturing cost and highly unstable cell culturing method mammalian culture is the largest due to post-translational mechanism present in living cells. Monoclonal antibodies are growing at a faster pace due to demand for biotech APIs and increasing venture capital investments that drives the market.

Key Topics Covered:

1 Executive Summary

2 Introduction

3 Market Analysis

3.1 Introduction

3.2 Market Segmentation

3.3 Factors Influencing Market

3.4 Regulatory Affairs

3.5 PorterâS Five Force Analysis

3.6 Supply Chain Analysis

3.7 Capacity Utilization

3.8 API Manufacturing Units

3.9 Selected Top Selling API

3.10 Market Share Analysis

4 Global API Market Overview

4.1 By Synthesis

4.2 By Customer Base

4.3 By Business Type

5 Global API Market, By Therapeutic Application

5.1 Introduction

5.2 Anti-Infectives

5.3 Oncology

5.4 Cardiovascular And Hematopoietic System

5.5 Central Nervous System

5.6 Respiratory System

5.7 Gastrointestinal

5.8 Hormone-Related Disorders

5.9 Metabolic Disorders

5.10 Genitourinary Disorders

5.11 Musculoskeletal Disorders

5.12 Others

6 Regional Market Analysis

7 Company Developments

7.1 Introduction

7.2 Approval

7.3 Agreements, Partnerships, Collaborations & Joint Ventures

7.4 New Product Launch

7.5 Mergers And Acquisitions

7.6 Other Developments

8 Major Player Profiles

8.1 Albemarle Corporation

8.2 Aurobindo Pharma Limited

8.3 Boehringer Ingelheim Gmbh

8.4 Dr. ReddyâS Laboratories Limited

8.5 Fresenius Kabi

8.6 Lonza Group Ltd

8.7 Lupin Limited

8.8 Novartis International Ag

8.9 Sun Pharmaceuticals Industries Ltd

8.10 Teva Active Pharmaceutical Ingredients

Companies Mentioned

– Aarti Drugs Ltd

– Abbvie

– Actavis Pharmaceuticals

– Ajantha Pharma

– Akorn

– Albany Molecular Research Inc (Amri)

– Alembic Ltd

– Amneal Pharmaceuticals Llc

– Apotex Fermentation Inc

– Aqvida Gmbh

– Arena Pharmaceuticals

– Arevipharma Gmbh

– Ariston Pharma Novatech Pvt Ltd

– Aurobindo Pharma

– Basf

– Bayer Pharma Chemicals

– Biocon Ltd

– Biodel Corporation

– Biosortia Pharmaceuticals

– Boehringer Ingelheim Gmbh

– Bristol-Myers Squibb

– Cadila Pharmaceuticals Limited

– Cambrex Corporation

– Catalent

– Century Pharmaceuticals Ltd

– Cepia Sanofi

– Cipla Limited

– Ckd Bio

– Corden Pharma

– Ctx Lifesciences

– Daiichi Sankyo Chemical Pharma Co Ltd

– Dishman Pharmaceuticals

– Dr.ReddyâS Laboratories

– Eirgen Pharma

– Emcure Pharmaceuticals Ltd

– Fermion

– Florentis Pharmaceuticals Pvt Ltd

– Global Merchants

– Heni Chemical Industries

– Indena

– Janssen Pharmaceutica Nv

– Kosher Pharmaceuticals

– Krka Pharmaceuticals

– Lannett

– Lilly Pharmaceuticals

– Liptis Pharmaceuticals

– Lonza Group

– Lupin

– Mallinckrodt Pharmaceuticals

– Medichem

– Megafine Pharma Ltd

– Merck Millipore

– Molcan

– Morepen

– Mylan N.V

– Nacto Pharma

– Nanomedex Pharmaceuticals

Novartis Ag

– Novasep

– Novo Nordisk

– Oncobiologics

– Orchid Chemicals & Pharmaceuticals Ltd

– Perrigo

– Pfizer

Pierre Fabre

– Princeton Biomolecular Research, Inc

– Python Biotech Llc

– Rablon Healthcare Pvt Ltd

– Reva Pharma Pvt Ltd

– Rpg Life Sciences

– Saamya Biotech

– Sandoz International Gmbh

– Saneca Pharmaceuticals

– Sanofi

– Salix Pharmaceuticals

– Scinopharm

– Shasun

– Shreeji Pharma International

– Sigma-Aldrich

– Sterling Biotech Ltd

– Sun Pharmaceutical Industries Ltd

– Surfachem

– Suven Life Science Ltd

– Symbiotec

– Takeda

– Taro Pharmaceuticals

– Teva Pharmaceuticals

– Trifecta Pharmaceuticals

– Welt Care Lifesciences Pvt Ltd

– Wockhardt

– Xellia Pharmaceuticals

For more information visit

Media Contact:

Research and Markets

Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716


SOURCE Research and Markets

Leave a Reply

Your email address will not be published. Required fields are marked *